Aberrant Pontin expression has been reported in liver cancer [14], colon carcinoma [15], renal cell carcinoma (RCC) [16], and acute myeloid leukemia (AML) [17]. This evidence concerns the gene RUVBL1 and hereditary clear cell renal cell carcinoma.